Related references
Note: Only part of the references are listed.Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences
Theresa M. Carbonaro et al.
PSYCHOPHARMACOLOGY (2018)
Psychedelic Drugs in Biomedicine
Evan J. Kyzar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Robin L. Carhart-Harris et al.
SCIENTIFIC REPORTS (2017)
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
Ricardo Jorge Dinis-Oliveira
DRUG METABOLISM REVIEWS (2017)
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Theresa M. Carbonaro et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol: Analytical Methods and Biologic Activities
Katarzyna Stebelska
THERAPEUTIC DRUG MONITORING (2013)
Harm potential of magic mushroom use: A review
Jan van Amsterdam et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Acute poisonings in Iceland: A prospective nationwide study
Jakob Kristinsson et al.
CLINICAL TOXICOLOGY (2008)
Validation of new methods
Frank T. Peters et al.
FORENSIC SCIENCE INTERNATIONAL (2007)
Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse
Markus Bickel et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2005)
The pharmacology of psilocybin
T Passie et al.
ADDICTION BIOLOGY (2002)
Share Paper
